Parathyroid hormone and systolic blood pressure accelerate the progression of aortic valve stenosis in chronic hemodialysis patients

International Journal of Cardiology

Volumn 163, Issue 3, 2013, Pages 256-259

  Iwata, Shinichi ^a   Hyodo, Eiichi ^b   Yanagi, Shiro ^a   Hayashi, Yusuke ^a   Nishiyama, Hiroyoshi ^a   Kamimori, Kimio ^a   Ota, Takahiro ^a   Matsumura, Yoshiki ^b   Homma, Shunichi ^c   Yoshiyama, Minoru ^b  

^a Department of Cardiology   (Japan)

^b OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c NewYork Presbyterian Hospital   (United States)

Author keywords

Aortic valve stenosis; Hemodialysis; Parathyroid hormone; Systolic blood pressure

Indexed keywords

CHOLESTEROL; CREATININE; PARATHYROID HORMONE;

AGE DISTRIBUTION; AGED; AORTA VALVE STENOSIS; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL EVALUATION; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; DISEASE COURSE; DISEASE SEVERITY; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART VENTRICLE SIZE; HEMODIALYSIS PATIENT; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PARATHYROID HORMONE BLOOD LEVEL; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SYSTOLIC BLOOD PRESSURE; AORTA VALVE; AORTIC VALVE AREA; CLINICAL ARTICLE; DISEASE ASSOCIATION; HEMODIALYSIS;

AGED; AORTIC VALVE STENOSIS; BIOLOGICAL MARKERS; BLOOD PRESSURE; CHRONIC DISEASE; COHORT STUDIES; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PARATHYROID HORMONE; RENAL DIALYSIS; RETROSPECTIVE STUDIES;

EID: 84874546142     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2011.06.025     Document Type: Article

References (20)

1. C.M. Otto, B.K. Lind, D.W. Kitzman, B.J. Gersh, and D.S. Siscovick Association of aortic-valve sclerosis with cardiovascular mortality and morbidity in the elderly N Engl J Med 341 1999 142 147
2. B.F. Stewart, D. Siscovick, and B.K. Lind Clinical factors associated with calcific aortic valve disease. Cardiovascular health study J Am Coll Cardiol 29 1997 630 634
3. S. Palta, A.M. Pai, K.S. Gill, and R.G. Pai New insights into the progression of aortic stenosis: implications for secondary prevention Circulation 101 2000 2497 2502
4. P.L. Michel Aortic stenosis in chronic renal failure patients treated by dialysis Nephrol Dial Transplant 13 Suppl. 4 1998 44 48
5. V. Perkovic, D. Hunt, S.V. Griffin, M. du Plessis, and G.J. Becker Accelerated progression of calcific aortic stenosis in dialysis patients Nephron Clin Pract 94 2003 c40 c45
6. T. Ohara, Y. Hashimoto, A. Matsumura, M. Suzuki, and M. Isobe Accelerated progression and morbidity in patients with aortic stenosis on chronic dialysis Circ J 69 2005 1535 1539
7. R.O. Bonow, B.A. Carabello, and K. Chatterjee Focused update incorporated into the acc/aha 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for the Management of Patients with Valvular Heart Disease): endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons Circulation 118 2008 e523 e661
8. N.B. Schiller, P.M. Shah, and M. Crawford Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American society of echocardiography committee on standards, subcommittee on quantitation of two-dimensional echocardiograms J Am Soc Echocardiogr 2 1989 358 367
9. J.K. Oh, C.P. Taliercio, and D.R. Holmes Prediction of the severity of aortic stenosis by Doppler aortic valve area determination: prospective Doppler-catheterization correlation in 100 patients J Am Coll Cardiol 11 1988 1227 1234
10. A. Simon, J. Gariepy, G. Chironi, J.L. Megnien, and J. Levenson Intima-media thickness: a new tool for diagnosis and treatment of cardiovascular risk J Hypertens 20 2002 159 169
11. P. Greenland, J. Abrams, and G.P. Aurigemma Prevention Conference V: beyond secondary prevention: identifying the high-risk patient for primary prevention: noninvasive tests of atherosclerotic burden: Writing Group III Circulation 101 2000 E16 E22
12. N. Fukuda, H. Tanaka, Y. Tominaga, M. Fukagawa, K. Kurokawa, and Y. Seino Decreased 1,25-dihydroxyvitamin d3 receptor density is associated with a more severe form of parathyroid hyperplasia in chronic uremic patients J Clin Invest 92 1993 1436 1443
13. M. Yamamoto, T. Igarashi, M. Muramatsu, M. Fukagawa, T. Motokura, and E. Ogata Hypocalcemia increases and hypercalcemia decreases the steady-state level of parathyroid hormone messenger RNA in the rat J Clin Invest 83 1989 1053 1056
14. M. Shuvy, S. Abedat, and R. Beeri Uraemic hyperparathyroidism causes a reversible inflammatory process of aortic valve calcification in rats Cardiovasc Res 79 2008 492 499
15. J. Braun, M. Oldendorf, W. Moshage, R. Heidler, E. Zeitler, and F.C. Luft Electron beam computed tomography in the evaluation of cardiac calcification in chronic dialysis patients Am J Kidney Dis 27 1996 394 401
16. G.E. Pate Association between aortic stenosis and hypertension J Heart Valve Dis 11 2002 612 614
17. J.T. Butcher, and R.M. Nerem Valvular endothelial cells and the mechanoregulation of valvular pathology Philos Trans R Soc Lond B Biol Sci 362 2007 1445 1457
18. L. Ge, and F. Sotiropoulos Direction and magnitude of blood flow shear stresses on the leaflets of aortic valves: is there a link with valve calcification? J Biomech Eng 132 2010 014505
19. +-sensing receptor in primary and uremic secondary hyperparathyroidism J Clin Endocrinol Metab 81 1996 1598 1606
20. Kdigo clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (ckd-mbd) Kidney Int Suppl 2009 S1 S130